
@ShahidNShah
At a time of unprecedented panic over the rapidly spreading COVID-19 coronavirus, several research groups are asking whether existing therapies could be repurposed in fighting the disease. Suggestions over the past week include combinations of drugs and supplements as well as a stem cell product that has proven effective in reducing inflammatory biomarkers.
Continue reading at fiercebiotech.com
It was a Sunday in mid-January when Amy Compton Phillips, chief clinical officer for Providence St. Joseph Health, was first alerted that a patient with COVID-19 had shown up at one of the health …
Posted Mar 17, 2020coronavirus
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2025 Netspective Foundation, Inc. All Rights Reserved.
Built on Mar 4, 2025 at 1:16pm